113 related articles for article (PubMed ID: 38279496)
21. Hypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.
Spitzwieser M; Entfellner E; Werner B; Pulverer W; Pfeiler G; Hacker S; Cichna-Markl M
BMC Cancer; 2017 Apr; 17(1):260. PubMed ID: 28403857
[TBL] [Abstract][Full Text] [Related]
22. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells.
Rice JC; Massey-Brown KS; Futscher BW
Oncogene; 1998 Oct; 17(14):1807-12. PubMed ID: 9778046
[TBL] [Abstract][Full Text] [Related]
23. Pyrosequencing quantified methylation level of BRCA1 promoter as prognostic factor for survival in breast cancer patient.
Cai FF; Chen S; Wang MH; Lin XY; Zhang L; Zhang JX; Wang LX; Yang J; Ding JH; Pan X; Shao ZM; Biskup E
Oncotarget; 2016 May; 7(19):27499-510. PubMed ID: 27027444
[TBL] [Abstract][Full Text] [Related]
24.
Khan F; Agarwal P; Gupta S; Maurya MK; Singh P; Agarwal A; Singh K; Sonkar AA; Goel MM
Indian J Med Res; 2023 Jan; 158(1):47-54. PubMed ID: 37602586
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of BRCA1 Gene Promoter Methylation Status in Sporadic Breast Cancer Patients in Southwest of Iran.
Hassani H; Talaiezadeh A; Tahmasebi Birgani M; Bijanzadeh M
Asian Pac J Cancer Prev; 2023 Mar; 24(3):811-817. PubMed ID: 36974532
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological significance of BRCA1 promoter hypermethylation in Thai breast cancer patients.
Saelee P; Chaiwerawattana A; Ogawa K; Cho YM; Tiwawech D; Suktangman V
Asian Pac J Cancer Prev; 2014; 15(24):10585-9. PubMed ID: 25605143
[TBL] [Abstract][Full Text] [Related]
27. BRCA1 deficiency is a recurrent event in early-onset triple-negative breast cancer: a comprehensive analysis of germline mutations and somatic promoter methylation.
Brianese RC; Nakamura KDM; Almeida FGDSR; Ramalho RF; Barros BDF; Ferreira ENE; Formiga MNDC; de Andrade VP; de Lima VCC; Carraro DM
Breast Cancer Res Treat; 2018 Feb; 167(3):803-814. PubMed ID: 29116469
[TBL] [Abstract][Full Text] [Related]
28. Curcumin induces re‑expression of BRCA1 and suppression of γ synuclein by modulating DNA promoter methylation in breast cancer cell lines.
Al-Yousef N; Shinwari Z; Al-Shahrani B; Al-Showimi M; Al-Moghrabi N
Oncol Rep; 2020 Mar; 43(3):827-838. PubMed ID: 32020216
[TBL] [Abstract][Full Text] [Related]
29. BRCA1-methylated sporadic breast cancers are BRCA-like in showing a basal phenotype and absence of ER expression.
Bal A; Verma S; Joshi K; Singla A; Thakur R; Arora S; Singh G
Virchows Arch; 2012 Sep; 461(3):305-12. PubMed ID: 22820987
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
[TBL] [Abstract][Full Text] [Related]
31. The association between the methylation frequency of BRCA1/2 gene promoter and occurrence and prognosis of breast carcinoma: A meta-analysis.
Li S; He Y; Li C; Liu X; Shen Y; Wu Y; Bai N; Li Q
Medicine (Baltimore); 2020 Mar; 99(10):e19345. PubMed ID: 32150073
[TBL] [Abstract][Full Text] [Related]
32. BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers.
Vos S; Moelans CB; van Diest PJ
Breast Cancer Res; 2017 May; 19(1):64. PubMed ID: 28569220
[TBL] [Abstract][Full Text] [Related]
33. Detection of hypermethylation BRCA1/2 gene promoter in breast tumours among Moroccan women.
Saif I; Bouziyane A; Benhessou M; Karroumi ME; Ennaji MM
Mol Biol Rep; 2021 Nov; 48(11):7147-7152. PubMed ID: 34591267
[TBL] [Abstract][Full Text] [Related]
34. Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer.
Yadav P; Masroor M; Nandi K; Kaza RCM; Jain SK; Khurana N; Saxena A
Asian Pac J Cancer Prev; 2018 Feb; 19(2):443-448. PubMed ID: 29480000
[TBL] [Abstract][Full Text] [Related]
35. Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy.
Xu Y; Diao L; Chen Y; Liu Y; Wang C; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Deng D; Narod SA; Xie Y
Ann Oncol; 2013 Jun; 24(6):1498-505. PubMed ID: 23406733
[TBL] [Abstract][Full Text] [Related]
36. BRCA1 Promoter Hypermethylation in Malignant Breast Tumors and in the Histologically Normal Adjacent Tissues to the Tumors: Exploring Its Potential as a Biomarker and Its Clinical Significance in a Translational Approach.
Oubaddou Y; Oukabli M; Fenniche S; Elktaibi A; Elochi MR; Al Bouzidi A; Qmichou Z; Dakka N; Diorio C; Richter A; Bakri Y; Ameziane El Hassani R
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761820
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic inactivation of BRCA1 through promoter hypermethylation in ovarian cancer progression.
Wang YQ; Yan Q; Zhang JR; Li SD; Yang YX; Wan XP
J Obstet Gynaecol Res; 2013 Feb; 39(2):549-54. PubMed ID: 23006047
[TBL] [Abstract][Full Text] [Related]
38. MYC overexpression and poor prognosis in sporadic breast cancer with BRCA1 deficiency.
Ren J; Jin F; Yu Z; Zhao L; Wang L; Bai X; Zhao H; Yao W; Mi X; Wang E; Olopade OI; Wei M
Tumour Biol; 2013 Dec; 34(6):3945-58. PubMed ID: 23860775
[TBL] [Abstract][Full Text] [Related]
39. Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients.
Pirouzpanah S; Taleban FA; Mehdipour P; Atri M
J Mol Med (Berl); 2015 Aug; 93(8):917-34. PubMed ID: 25805039
[TBL] [Abstract][Full Text] [Related]
40. Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifier.
Chen Y; Wang Y; Salas LA; Miller TW; Mark K; Marotti JD; Kettenbach AN; Cheng C; Christensen BC
Breast Cancer Res; 2019 Jan; 21(1):14. PubMed ID: 30683142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]